 |
市场调查报告书
商品编码
1085634
内臟器官保存溶液市场:各溶液类型，各技术类型，各地区-规模，占有率，展望，机会分析-2022～2028年Organ Preservation Solutions Market, By Solution Type, By Technique Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 |
||||||
价格
简介目录
阻碍全球内臟器官保存溶液市场在预测期间内的成长的主要原因，是干细胞的出现和高成本。
本报告提供全球内臟器官保存溶液市场相关调查分析，市场促进因素，阻碍因素，市场机会，各焊接类型、技术类型、终端用户、地区市场分析，企业简介相关资讯。
目录
第1章 调查目的、前提条件
- 调查目的
- 假设
- 简称
第2章 市场展望
- 报告的说明
- 市场定义和范围
- 摘要整理
- 市场明细:各溶液类型
- 市场明细:各技术类型
- Coherent Opportunity Map(COM)
第3章 市场动态，法规，及趋势分析
- 市场动态
- 促进因素
- 阻碍因素
- 市场机会
- 影响分析
- 主要的发展
- 法规情境
- PEST分析
- COVID-19影响分析
第4章 全球内臟器官保存溶液市场:各溶液类型(2017～2028年(100万美元))
- 简介
- 市场占有率分析:2022年及2028年(%)
- 与前一年同期比较成长分析:2017～2028年
- 市场区隔趋势
- Viaspan
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 市场区隔趋势
- Custodiol HTK
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 市场区隔趋势
- Renograf
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 市场区隔趋势
- Hypothermosol
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 市场区隔趋势
- Perfadex
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 市场区隔趋势
- Lifor
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 市场区隔趋势
- HBS溶液
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 市场区隔趋势
- siRNA
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 市场区隔趋势
- 其他
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 市场区隔趋势
第5章 全球内臟器官保存溶液市场:各技术类型(2017～2028年(100万美元))
- 简介
- 市场占有率分析:2022年及2028年(%)
- 与前一年同期比较成长分析:2017～2028年
- 市场区隔趋势
- 低体温灌流保存
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 静态冷资料储存(SCS)
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 其他
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
第6章 全球内臟器官保存溶液市场:各终端用户(2017～2028年(100万美元))
- 简介
- 市场占有率分析:2022年及2028年(%)
- 与前一年同期比较成长分析:2017～2028年
- 市场区隔趋势
- 公共/民间的医疗机关
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 医生
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 医护人员
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 个人
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
第7章 全球内臟器官保存溶液市场:各地区(2017～2028年(100万美元))
- 简介
- 市场占有率分析:2022年及2028年(%)
- 与前一年同期比较成长分析:2017～2028年
- 市场区隔趋势
- 北美
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 美国
- 加拿大
- 欧洲
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
- 亚太地区
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 中国
- 印度
- 日本
- 东南亚国家联盟
- 澳洲
- 韩国
- 其他亚太地区
- 南美
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 巴西
- 墨西哥
- 阿根廷
- 其他南美国家
- 中东
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 海湾合作理事会
- 以色列
- 其他中东
- 非洲
- 简介
- 市场规模与预测，及与前一年同期比较成长率:2017～2028年(100万美元))
- 北非
- 中非
- 南非
第8章 竞争情形
- 企业简介
- Teva Pharmaceutical Industries Ltd.
- Dr. Franz Kohler Chemie GmbH
- BioLife Solutions
- XVIVO Perfusion AB
- Bristol-Myers Squibb, Inc.
- ToleroTech, Inc.
- Lifeline Scientific
- Preservation Solutions Inc.
- Claris Injectables Limited
- 21st Century Medicine
- Paragonix Technologies Inc.
- BioTime, Inc.
- CryoLife, Inc.
第9章 Section
简介目录
Product Code: CMI1072
Organ preservation involves removal of organs from the bodies, which are then stored for transplantation. Organ preservation systems are exclusively prepared and maintained according to the biological environment (temperature and oxygen) needed to store particular organs. Different body organs require specific and suitable storage conditions to maintain their anatomical and physiological processes. Important parameters in organ preservation include delivering of high quality organs to the donors, matching the patient and organ suitability, and restart of life of the organs and sustaining functions after the transplantation. Organ transplantation process starts with removing the needed organ from the donor body, then the organ is stored and transported.
Restraints of the Global Organ Preservation Solutions Market
Major factors hampering the growth of the organ preservation solutions market during the forecast period constitutes of advent of stem cells, and high costs.
Key features of the study:
- This report provides in-depth analysis of the global organ preservation solutions market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global organ preservation solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Franz Kohler Chemie GmbH, BioLife Solutions, XVIVO Perfusion AB, Bristol-Myers Squibb, Inc., and ToleroTech, Inc., Lifeline Scientific, Preservation Solutions Inc., Claris Injectables Limited, 21st Century Medicine, Paragonix Technologies Inc., BioTime, Inc. CryoLife, Inc., and Dr. Franz Kohler Chemie GmbH.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global organ preservation solutions market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
- Global Organ Preservation Solutions Market, By Solution Type:
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- Global Organ Preservation Solutions Market, By Technique Type:
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- Global Organ Preservation Solutions Market, By Geography:
- North America
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- U.S.
- Canada
- Europe
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East:
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country/Region:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Teva Pharmaceutical Industries Ltd.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Dr. Franz Kohler Chemie GmbH
- BioLife Solutions
- XVIVO Perfusion AB
- Bristol-Myers Squibb, Inc.
- ToleroTech, Inc.
- Lifeline Scientific
- Preservation Solutions Inc.
- Claris Injectables Limited
- 21st Century Medicine
- Paragonix Technologies Inc.
- BioTime, Inc.
- CryoLife, Inc.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Solution Type
- Market Snippet, By Technique Type
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
4. Global Organ Preservation Solutions Market, By Solution Type, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Viaspan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Custodiol HTK
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Renograf
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Hypothermosol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Perfadex
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Lifor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- HBS Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- siRNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
5. Global Organ Preservation Solutions Market, By Technique Type, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hypothermic Perfusion Preservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Static Cold Storage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Organ Preservation Solutions Market, By End User, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Public/Private healthcare institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Physicians
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Healthcare workers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Individuals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Organ Preservation Solutions Market, By Regions, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dr. Franz Kohler Chemie GmbH
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioLife Solutions
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- XVIVO Perfusion AB
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ToleroTech, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lifeline Scientific
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Preservation Solutions Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Claris Injectables Limited
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 21st Century Medicine
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Paragonix Technologies Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioTime, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CryoLife, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Section
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
器官保存市场评估：按解决方案、技术、器官类型、最终用户和地区划分的机会和预测（2017-2031）
2024-2032 年器官保存市场报告（按保存解决方案、器官捐赠类型、技术、器官类型、最终用户和地区）
2024 年全球器官保存解决方案市场报告
到 2030 年器官保存解决方案市场预测：按解决方案、保存类型、器官、最终用户和地区进行的全球分析
器官保存解决方案市场- 按解决方案（威斯康辛大学、Custodiol HTK、Perfadex、Celsior）、保存类型（静态冷藏、低温、常温）、器官（肾、肝、肺）、最终用户、全球预测（2023年- ）第2032章
2023-2027年全球器官保存市场
亚太地区器官保存解决方案市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型、应用程式、器官类型和最终用户
北美器官保存解决方案市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型、应用程式、器官类型和最终用户
南美洲和中美洲器官保存解决方案市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型、应用程式、器官类型最终用户
欧洲器官保存解决方案市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型、应用程式、器官类型和最终用户
▼